{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T05:31:54Z","timestamp":1671514314397},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HNO"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s00106-012-2494-1","type":"journal-article","created":{"date-parts":[[2012,6,5]],"date-time":"2012-06-05T19:40:09Z","timestamp":1338925209000},"page":"496-504","source":"Crossref","is-referenced-by-count":5,"title":["Pharmakologie der Botulinumtoxinmedikamente"],"prefix":"10.1007","volume":"60","author":[{"given":"D.","family":"Dressler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,6,7]]},"reference":[{"key":"2494_CR1","doi-asserted-by":"crossref","unstructured":"Antonucci F, Rossi C, Gianfranceschi L et al (2008) Long-distance retrograde effects of botulinum neurotoxin A J Neurosci 28:3689\u20133696","DOI":"10.1523\/JNEUROSCI.0375-08.2008"},{"key":"2494_CR2","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/0333102410364676","volume":"30","author":"Aurora","year":"2010","unstructured":"Aurora SK, Dodick DW, Turkel CC et al (2010) OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia 30:793\u2013803","journal-title":"Cephalalgia"},{"key":"2494_CR3","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1212\/01.WNL.0000163767.99354.C3","volume":"64","author":"Benecke","year":"2005","unstructured":"Benecke R, Jost WH, Kanovsky P et al (2005) A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia. Neurology 64:1949\u20131951","journal-title":"Neurology"},{"key":"2494_CR4","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0021-9258(17)42071-0","volume":"269","author":"Binz","year":"1994","unstructured":"Binz T, Blasi J, Yamasaki S et al (1994) Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. J Biol Chem 269:1617\u20131620","journal-title":"J Biol Chem"},{"key":"2494_CR5","unstructured":"Brin MF, Dressler D, Aoki R (2004) Pharmacology of botulinum toxin therapy. In: Jankovic J, Comella C, Brin MF (Hrsg) Dystonia: etiology, clinical features, and treatment. Lippincott Williams & Wilkins, Philadelphia, S\u00a093\u2013112"},{"key":"2494_CR6","doi-asserted-by":"crossref","first-page":"R17","DOI":"10.1007\/s00210-001-0491-0","volume":"365","author":"Cui","year":"2002","unstructured":"Cui M, Li Z, You S et al (2002) Mechanisms of the antinociceptive effect of subcutaneous Botox: inhibition of peripheral and central nociceptive processing. Arch Pharmacol 365:R17","journal-title":"Arch Pharmacol"},{"key":"2494_CR7","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1073\/pnas.96.6.3200","volume":"96","author":"Paiva","year":"1999","unstructured":"Paiva A de, Meunier FA, Molgo J et al (1999) Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci USA 96:3200\u20133205","journal-title":"Proc Natl Acad Sci USA"},{"key":"2494_CR8","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1177\/0333102410364677","volume":"30","author":"Diener","year":"2010","unstructured":"Diener HC, Dodick DW, Aurora SK et al (2010) Chronic migraine study group. onabotulinumtoxina for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia 30:804\u2013814","journal-title":"Cephalalgia"},{"key":"2494_CR9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1468-1331.2009.02877.x","volume":"16","author":"Dressler","year":"2009","unstructured":"Dressler D (2009) Routine use of Xeomin\u00ae in patients pre-treated with Botox\u00ae. Eur J Neurol 16 (Suppl 2):2\u20135","journal-title":"Eur J Neurol"},{"key":"2494_CR10","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00702-010-0481-9","volume":"117","author":"Dressler","year":"2010","unstructured":"Dressler D (2010) Subclinical myasthenia gravis causing increased sensitivity to botulinum toxin therapy. J Neural Transm 117:1293\u20131294","journal-title":"J Neural Transm"},{"key":"2494_CR11","first-page":"S640","volume":"21","author":"Dressler","year":"2006","unstructured":"Dressler D, Adib Saberi F (2006) First high dose use of complex free botulinum toxin type A. Mov Disord 21(Suppl 15):S640","journal-title":"Mov Disord"},{"key":"2494_CR12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000067023","volume":"49","author":"Dressler","year":"2003","unstructured":"Dressler D, Benecke R (2003) Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis. Eur Neurol 49:34\u201338","journal-title":"Eur Neurol"},{"key":"2494_CR13","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1055\/s-2005-915441","volume":"33","author":"Dressler","year":"2006","unstructured":"Dressler D, Benecke R (2006) Xeomin\u00ae eine neue therapeutische Botulinum Toxin Typ A-Pr\u00e4paration. Akt Neurol 33:138\u2013141","journal-title":"Akt Neurol"},{"key":"2494_CR14","first-page":"386","volume":"60","author":"Dressler","year":"1989","unstructured":"Dressler D, Benecke R, Conrad B (1989) Botulinum-Toxin in der Therapie kraniozervikaler Dystonien. Nervenarzt 60:386\u2013394","journal-title":"Nervenarzt"},{"key":"2494_CR15","first-page":"51","volume":"15","author":"Dressler","year":"2000","unstructured":"Dressler D, Dirnberger G (2000) Botulinum toxin therapy: risk factors for therapy failure. Mov Disord 15 (suppl 2):51","journal-title":"Mov Disord"},{"key":"2494_CR16","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00415-003-1129-6","volume":"250","author":"Dressler","year":"2003","unstructured":"Dressler D, Benecke R, Bigalke H (2003) Botulinum toxin type B (NeuroBloc\u00ae) in patients with botulinum toxin type A antibody-induced therapy failure. J Neurol 250:967\u2013969","journal-title":"J Neurol"},{"key":"2494_CR17","first-page":"20","volume":"23","author":"Dressler","year":"2008","unstructured":"Dressler D, Mander G, Fink K (2008) Equivalent potency of xeomin\u00ae and botox\u00ae. Mov Disord 23(Suppl 1):20\u201321","journal-title":"Mov Disord"},{"key":"2494_CR18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0022-510X(71)90129-8","volume":"14","author":"Duchen","year":"1971","unstructured":"Duchen LW (1971) An electron microscopic study of the changes induced by botulinum toxin in the motor end-plates of slow and fast skeletal muscle fibres of the mouse. J Neurol Sci 14:47\u201360","journal-title":"J Neurol Sci"},{"key":"2494_CR19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0022-510X(71)90130-4","volume":"14","author":"Duchen","year":"1971","unstructured":"Duchen LW (1971) Changes in the electron microscopic structure of slow and fast skeletal muscle fibres of the mouse after the local injection of botulinum toxin. J Neurol Sci 14:61\u201374","journal-title":"J Neurol Sci"},{"key":"2494_CR20","first-page":"49P","volume":"94","author":"Eckert","year":"1995","unstructured":"Eckert J, Dressler D, Kukowski B (1995) Pathologic SEP findings in writer\u2019s cramp. EEG Clin Neurophysiol 94:49P","journal-title":"EEG Clin Neurophysiol"},{"key":"2494_CR21","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.toxicon.2010.12.019","volume":"57","author":"Eisele","year":"2011","unstructured":"Eisele KH, Fink K, Vey M, Taylor HV (2011) Studies on the dissociation of botulinum neurotoxin type A complexes. Toxicon 57:555\u2013565","journal-title":"Toxicon"},{"key":"2494_CR22","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/jnnp.56.11.1235","volume":"56","author":"Erbguth","year":"1993","unstructured":"Erbguth F, Claus D, Engelhardt A, Dressler D (1993) Systemic effect of local botulinum toxin injections unmasks subclinical Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiat 56:1235\u20131236","journal-title":"J Neurol Neurosurg Psychiat"},{"key":"2494_CR23","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3109\/00016489309135834","volume":"113","author":"Filippi","year":"1993","unstructured":"Filippi GM, Errico P, Santarelli R et al (1993) Botulinum A toxin effects on rat jaw muscle spindles. Acta Otolaryngol 113:400\u2013404","journal-title":"Acta Otolaryngol"},{"key":"2494_CR24","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1021\/bi9519009","volume":"35","author":"Foran","year":"1996","unstructured":"Foran P, Lawrence GW, Shone CC et al (1996) Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release. Biochemistry 35:2630\u20132636","journal-title":"Biochemistry"},{"key":"2494_CR25","first-page":"325","volume":"4","author":"Frevert","year":"2010","unstructured":"Frevert J, Dressler D (2010) Complexing proteins in botulinum toxin type A drugs \u2013 a help or hindrance? Biologics 4:325\u2013332","journal-title":"Biologics"},{"key":"2494_CR26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0021-5155(99)00197-5","volume":"44","author":"Ishikawa","year":"2000","unstructured":"Ishikawa H, Mitsui Y, Yoshitomi T et al (2000) Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles. Jpn J Ophthalmol 44:106\u2013109","journal-title":"Jpn J Ophthalmol"},{"key":"2494_CR27","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1212\/01.WNL.0000055087.96356.BB","volume":"60","author":"Jankovic","year":"2003","unstructured":"Jankovic J, Vuong KD, Ahsan J (2003) Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia. Neurology 60:1186\u20131188","journal-title":"Neurology"},{"key":"2494_CR28","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/mus.880180214","volume":"18","author":"Kaji","year":"1995","unstructured":"Kaji R, Kohara N, Katayama M et al (1995) Muscle afferent block by intramuscular injection of lidocaine for the treatment of writer\u2019s cramp. Muscle Nerve 18:234\u2013235","journal-title":"Muscle Nerve"},{"key":"2494_CR29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ana.410380206","volume":"l38","author":"Kaji","year":"1995","unstructured":"Kaji R, Rothwell JC, Katayama M et al (1995) Tonic vibration reflex and muscle afferent block in writer\u2019s cramp. Ann Neurol l38:155\u2013162","journal-title":"Ann Neurol"},{"key":"2494_CR30","first-page":"1","volume":"3","author":"Kerner","year":"1817","unstructured":"Kerner J (1817) Vergiftung durch verdorbene W\u00fcrste. T\u00fcbinger Bl\u00e4tter Naturwissensch Arzneykunde 3:1\u201325","journal-title":"T\u00fcbinger Bl\u00e4tter Naturwissensch Arzneykunde"},{"key":"2494_CR31","unstructured":"Kerner J (1820) Neue Beobachtungen \u00fcber die in W\u00fcrthemberg so h\u00e4ufig vorfallenden t\u00f6dlichen Vergiftungen durch den Genu\u00df ger\u00e4ucherter W\u00fcrste. GF Osiander, T\u00fcbingen"},{"key":"2494_CR32","unstructured":"Kerner J (1822) Das Fettgift und die Fetts\u00e4ure und ihre Wirkungen auf den thierischen Organismus. Ein Beytrag zur Untersuchung des in verdorbenen W\u00fcrsten giftig wirkenden Stoffes. Cotta, Stuttgart"},{"key":"2494_CR33","doi-asserted-by":"crossref","first-page":"21338","DOI":"10.1016\/S0021-9258(19)36614-1","volume":"267","author":"McMahon","year":"1992","unstructured":"McMahon H, Foran P, Dolly J (1992) Tetanus toxin and botulinum toxins type A and B inhibit glutamate, gamma-aminobutyric acid, aspartate, and met-enkephalin release from synaptosomes: clues to the locus of action. J Biol Chem 267:21338\u201321343","journal-title":"J Biol Chem"},{"key":"2494_CR34","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1152\/ajpheart.2001.281.5.H2124","volume":"281","author":"Morris","year":"2001","unstructured":"Morris J, Jobling P, Gibbins I (2001) Differential inhibition by botulinum neurotoxin A of cotransmitters released from autonomic vasodilator neurons. Am J Physiol Heart Circ Physiol 281:2124\u20132132","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2494_CR35","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1098\/rstb.1999.0377","volume":"354","author":"Pellizzari","year":"1999","unstructured":"Pellizzari R, Rossetto O, Schiavo G, Montecucco C (1999) Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses. Philos Trans R Soc Lond B Biol Sci 354:259\u2013268","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"2494_CR36","unstructured":"Pickett A, Panjwani N, O\u2019Keeffe RS (2003) Potency of Type A Botulinum Toxin preparations in clinical use. 40th Annual Meeting of the Interagency Botulism Research Coordinating Committee (IBRCC), Nov. 2003, Atlanta, USA"},{"key":"2494_CR37","first-page":"S49","volume":"17","author":"Probst","year":"2002","unstructured":"Probst TE, Heise H, Heise P et al (2002) Rare immunologic side effects of botulinum toxin therapy: brachial plexus neuropathy and dermatomyositis. Mov Disord 17(suppl 5):S49","journal-title":"Mov Disord"},{"key":"2494_CR38","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0006-2952(00)00260-4","volume":"59","author":"Purkiss","year":"2000","unstructured":"Purkiss J, Welch M, Doward S, Foster K (2000) Capsaicin-stimulated release of substance P from cultured dorsal root ganglion neurons: involvement of two distinct mechanisms. Biochem Pharmacol 59:1403\u20131406","journal-title":"Biochem Pharmacol"},{"key":"2494_CR39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1055\/s-2008-1050804","volume":"189","author":"Roggenk\u00e4mper","year":"1986","unstructured":"Roggenk\u00e4mper P (1986) Blepharospasmus-Behandlung mit Botulinus-Toxin: Verlaufsbeobachtungen. Klin Monbl Augenheilkd 189:283\u2013285","journal-title":"Klin Monbl Augenheilkd"},{"key":"2494_CR40","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00702-005-0323-3","volume":"113","author":"Roggenk\u00e4mper","year":"2006","unstructured":"Roggenk\u00e4mper P, Jost WH, Bihari K et al (2006) Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm. J Neural Transm 113:303\u2013312","journal-title":"J Neural Transm"},{"key":"2494_CR41","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<488::AID-MUS9>3.0.CO;2-8","volume":"19","author":"Rosales","year":"1996","unstructured":"Rosales RL, Arimura K, Takenaga S, Osame M (1996) Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection. Muscle Nerve 19:488\u2013496","journal-title":"Muscle Nerve"},{"key":"2494_CR42","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1212\/WNL.36.4.545","volume":"36","author":"Sanders","year":"1986","unstructured":"Sanders DB, Massey EW, Buckley EG (1986) Botulinum toxin for blepharospasm: single-fibre EMG studies. Neurology 36:545\u2013547","journal-title":"Neurology"},{"key":"2494_CR43","unstructured":"Schantz EJ (1994) Historical Perspective. In: Jankovic J, Hallett M (Hrsg) Therapy with Botulinum Toxin. Marcel Dekker Inc, New York, S\u00a0XXIII\u2013XXVI"},{"key":"2494_CR44","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/359832a0","volume":"359","author":"Schiavo","year":"1992","unstructured":"Schiavo G, Benfenati F, Poulain B et al(1992) Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 359:832\u2013835","journal-title":"Nature"},{"key":"2494_CR45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0014-5793(93)80448-4","volume":"335","author":"Schiavo","year":"1993","unstructured":"Schiavo G, Santucci A, Dasgupta BR et al (1993) Botulinum neurotoxins serotypes A and E cleave SNAP-25\u00a0at distinct COOH-terminal peptide bonds. FEBS Lett 335:99\u2013103","journal-title":"FEBS Lett"},{"key":"2494_CR46","unstructured":"Schrader C, Tacik P, Ebke M, Dressler D (in press) Botulinum toxin therapy in the presence of anticoagulation: Hematoma frequency. Toxicon"},{"key":"2494_CR47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3928\/0191-3913-19800101-06","volume":"17","author":"Scott","year":"1980","unstructured":"Scott AB (1980) Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. J Pediatr Ophthalmol Strabismus 17:21\u201325","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"2494_CR48","unstructured":"Scott AB (1994) Foreword. In: Jankovic J, Hallett M (Hrsg) Therapy with Botulinum Toxin. Marcel Dekker, Inc, New York, S\u00a0VII\u2013IX"},{"key":"2494_CR49","first-page":"924","volume":"12","author":"Scott","year":"1973","unstructured":"Scott AB, Rosenbaum A, Collins CC (1973) Pharmacologic weakening of extraocular muscles. Invest Ophthalmol 12:924\u2013927","journal-title":"Invest Ophthalmol"},{"key":"2494_CR50","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1212\/WNL.55.10.22A","volume":"55","author":"Setler","year":"2000","unstructured":"Setler P (2000) The biochemistry of botulinum toxin type B. Neurology 55(Suppl 5):22\u201328","journal-title":"Neurology"},{"key":"2494_CR51","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1432-1033.1992.tb17137.x","volume":"207","author":"Shone","year":"1992","unstructured":"Shone CC, Melling J (1992) Inhibition of calcium-dependent release of noradrenaline from PC12 cells by botulinum type-A neurotoxin. Long-term effects of the neurotoxin on intact cells. Eur J Biochem 207:1009\u20131016","journal-title":"Eur J Biochem"},{"key":"2494_CR52","doi-asserted-by":"crossref","unstructured":"Truong D, Dressler D, Hallett M (2009) Manual of Botulinum Toxin therapy. Cambridge University Press, Cambridge","DOI":"10.1017\/CBO9780511575761"},{"key":"2494_CR53","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0041-0101(99)00153-1","volume":"38","author":"Welch","year":"2000","unstructured":"Welch MJ, Purkiss JR, Foster KA (2000) Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins. Toxicon 38:245\u2013258","journal-title":"Toxicon"},{"key":"2494_CR54","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF00498587","volume":"292","author":"Wiegand","year":"1976","unstructured":"Wiegand H, Erdmann G, Wellhoner HH (1976) 125I-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection. Naunyn Schmiedebergs Arch Pharmacol 292:161\u2013165","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2494_CR55","doi-asserted-by":"crossref","first-page":"12764","DOI":"10.1016\/S0021-9258(18)99941-2","volume":"269","author":"Yamasaki","year":"1994","unstructured":"Yamasaki S, Baumeister A, Binz T et al (1994) Cleavage of members of the synaptobrevin\/VAMP family by types D and F botulinal neurotoxins and tetanus toxin. J Biol Chem 269:12764\u201312772","journal-title":"J Biol Chem"},{"key":"2494_CR56","first-page":"49","volume":"74","author":"Dressler","year":"2009","unstructured":"Dressler D, Adib Saberi F (2009) Botulinum Toxin: Vom Medikament zum Toxin. Akt Neurol 74 (Suppl\u00a01): 49\u201354","journal-title":"Akt Neurol"}],"container-title":["HNO"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-012-2494-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00106-012-2494-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-012-2494-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T18:40:42Z","timestamp":1642358442000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00106-012-2494-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["2494"],"URL":"https:\/\/doi.org\/10.1007\/s00106-012-2494-1","relation":{},"ISSN":["0017-6192","1433-0458"],"issn-type":[{"value":"0017-6192","type":"print"},{"value":"1433-0458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}